Abstract
Background
Despite its importance, determination of competence to consent to organ donation varies widely based on local standards. We piloted a new tool to aid transplant centers in donor assessment.
Methods
We assessed competence-related abilities among potential living liver donors (LDs) in the 9-center A2ALL study. Prospective LDs viewed an educational video, and were queried to assess Understanding, Appreciation, Reasoning, and ability to express a Final Choice using the MacArthur Competence Assessment Tool for Clinical Research, adapted for computerized administration in LDs (“MacLiver”). Videotaped responses were scored by a clinical neuropsychologist (JF).
Results
Ninety-three LDs were assessed. Mean (standard deviation; domain maximum) scores were: Understanding: 18.1 (2.6; max=22), Appreciation: 5.1 (1.0; max=6), Reasoning: 3.1 (0.8; max=4), and Final Choice: 3.8 (0.5; max=4). Scores did not differ by demographics, relationship to the recipient, eligibility to donate, or eventual donation (p>0.4). Higher education was associated with greater Understanding (p=0.004) and Reasoning (p=0.03).
Conclusion
Standardized, computerized education with independent ratings of responses may (1) alert the clinical staff to potential donors who may not be competent to donate, and (2) highlight areas needing further assessment and education, leading to better informed decision-making.
Keywords: Living Donation, Comprehension, MacArthur Competence Assessment Tool for Clinical Research, Informed Consent, Ethics, Transplantation
Introduction
Adult-to-adult living donor liver transplantation (LDLT) is an alternative to deceased donor transplantation that can reduce waiting time and improve outcomes (1). This procedure presents difficult choices to patients and families, as it requires the living donor (LD) to undergo an operation with an estimated risk tenfold that of donating a kidney (2,3). The death of a LD immediately after donation in 2002, and two more donor deaths in 2010 (4), led to increased scrutiny of the living donation process. In 2002, the Advisory Committee on Organ Transplantation (ACOT) developed 18 consensus guidelines to make the process as “safe and effective as possible, for both the living organ donor and the recipient,” while maintaining the efficacy of living donation and transplantation (http://www.organdonor.gov/acotRecs1-18.asp). Foremost among these guidelines is that suitable donors be competent. Subsequently, international conferences organized by The Transplantation Society on care of live kidney (2003) and extra-renal (2005) donors reaffirmed that live organ donors must be competent (7–9). Competence to agree to a LDLT entails several abilities, including comprehension, appreciation, reasoning, and decision-making that have been defined in the literature and have become the basis for objective evaluation in both medical and legal settings(5,6). Despite consensus regarding the requirement of competence, there is no standard metric for measuring competence, and the process of assessment varies widely based on local standards (10–12).
The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL), a consortium of nine U.S. transplant centers tasked to study adult-to-adult LDLT between 2002 and 2009, included potential donors and recipients in a retrospective (1998–2003) and prospective (2004–2009) study of clinical practice and outcomes. During the retrospective study (13), we recognized that the nine centers did not assess competence-related abilities uniformly. Based on the competence domains noted above, we adapted the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) for LDs (“MacLiver”) to provide information about the living donation process in a standardized computer format, and query the subject’s ability to comprehend and make choices. We sought to provide an initial competence screening that could inform the transplant staff of areas of lower comprehension in potential donors so that educational efforts or evaluations could be appropriately targeted.
The specific goals of this study were to assess the inter-rater reliability of MacLiver scoring, develop preliminary normative distributions for domain-specific scores, and assess covariate effects on these scores. The longer term goal was to assess this tool for use in clinical practice.
Participants and Methods
A2ALL cohort study and methods
Participant enrollment into the prospective arm of A2ALL has been described elsewhere (14). In brief, all prospective LDs were eligible. On the day the prospective LD was first evaluated at the transplant center, the study intervention was explained and the opportunity to enroll was offered. Following enrollment, the MacLiver was the first center-provided educational material given and was given only at the start of the first visit. All study procedures were approved by the Institutional Review Board (IRB) at each study site and at the Data Coordinating Center (DCC), and written, informed consent was obtained from all participants. We note that the requirement of informed consent for this study guaranteed a level of competence for study participants.
The MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR)
The MacCAT-CR is a structured format to assess competence of participants in clinical research (15) that can be adapted for a variety of research settings. It is widely used to assess patients in whom competence is uncertain, such as those with Alzheimer’s disease or psychiatric disorders (16, 17), and its psychometric properties are well established (18). The MacCAT-CR is typically designed for a live interview setting. However, in adapting the MacCAT-CR for the LD setting, it was modified into a computer-administered presentation to provide a standardized education and assessment format at the nine A2ALL clinical centers, and was given the name MacLiver.
The script of the educational component was created by members of the A2ALL consortium to meet ACOT guidelines for information about the donation process, risks, and outcomes to disclose to prospective LDs as part of the informed consent process. Based on the script, Paul Appelbaum, MD, coauthor of the MacCAT-CR, assisted in generating the MacLiver to specifically 1) provide standardized education and 2) uniformly assess competence in the prospective LD population. The MacLiver script and the comprehension questions (see SDC, Appendix), read by professional actors, were produced and adapted for video presentation on a tablet computer by Clinaero, Inc. (Bellevue, WA; www.clinaero.com).
The computer tablet presentation included individual modules, each containing a short educational lecture immediately followed by a question/answer session where the potential LDs answers were captured by a built-in microphone and camera. The modules comprised the MacLiver competence domains: understanding the donor evaluation process, understanding the risks and benefits of donation, understanding the right to refuse without consequence, appreciating the impact of donation, expressing a clear decision to move forward or not, and providing clear reasoning for that decision. Responses were uploaded from the tablets to Clinaero, Inc., which forwarded the files to the study psychologist (JF) for scoring, as described below.
Due to a combination of problems including clinic logistics (primarily the earlier arrival time required to take the MacLiver before clinical visits), Clinaero software problems, and patient refusals, only 169 of 721 (23%) LDs participated in the electronic portion of the data collection. Of these, 31 files had insufficient recorded responses (fewer than 13 of 18 responses) and 45 were not recovered from the tablets, leaving 93 scorable files. Of these, 76 contained both audio and video information, while 17 were “audio only” files due to additional video recording complications. The latter files were coded solely using the audiotaped responses.
Scoring of the MacLiver
The assessment component of the MacLiver encompassed 18 questions categorized into four domains. Understanding comprised four sub-domains: knowledge of the components of the prospective LD evaluation, the purpose of the MacLiver evaluation, the possible risks and benefits, and understanding the right to terminate the evaluation process at any time without repercussion (11 questions). Appreciation reflected how the risks and benefits could specifically impact the life and well-being of the prospective LD (3 questions). Reasoning related to the rationale used to make the decision to donate (2 questions). Lastly, Final Choice referred to the ability to express a clear decision (2 questions). Each question was scored as 2, 1, or 0 points. A score of 2 was assigned when responses indicated good comprehension of all required elements (see SDC, Appendix) and/or reflected good application of the information, including but not limited to that given by the script. A score of 1 was assigned when a key element of information was missing, or if an overly vague or concrete answer was provided. Zero points were given for responses that were inaccurate, fully insufficient, or when the respondent could not provide a response.
Clinical donor evaluation process
Following the MacLiver, prospective LDs underwent center-specific clinical evaluation. The assessment determined mental and physical suitability, including motivation, medical evaluation of overall health, suitability and morphology of the liver, and psychosocial evaluation of competence to consent for donation. Under the A2ALL protocol, acceptance for donation was determined by the local evaluating team using local standards to determine competence and psychosocial stability. The clinical teams evaluating the donors were blinded to the MacLiver assessment. Clinical data elements, including whether the prospective LD was ruled out for donation and the reason for the rule out, were recorded in the A2ALL database.
Post-donation perception of donation items
For those who donated, we collected data three months post-donation via a standardized survey on LDs’ perceived preparation for donation, perceived stress about the donation experience, and overall feelings about living donation (19). We compared these items between MacLiver completers and non-completers to determine whether completing the MacLiver predicted their sense of preparedness or feelings about the donation experience.
Data analysis
Multiple imputation was used to impute the missing items for participants with complete data for at least 13 of the 18 MacLiver items (20–22).Five imputation datasets were generated, and all subsequent analyses were performed by pooling the results from these five datasets. The SAS™ MI and MIAnalyze procedures were used for the imputation and subsequent analyses. Comparisons between groups were performed using two-sample t-tests for continuous variables, and using chi-square tests for dichotomous variables.
Results
Study population and demographics
Table 1 compares demographic and other characteristics of potential donors who did and did not complete the MacLiver. In general, the MacLiver participants were more likely to have education beyond high school, and were also more likely to donate, partly because the non-MacLiver group had more contraindications in their potential recipients. Overall, participants had a mean age of 39 years, were nearly equally divided by sex, were predominantly non-Hispanic white, and most had education beyond high school. Nearly two-thirds of participants were biologically related to the candidate. Over half of the evaluated donors did not donate, largely due to medical and anatomical contraindications or changes in the situation of the recipient.
Table 1.
Characteristic | MacLiver* (n=169) |
Non-MacLiver (n=552) |
P-Value |
---|---|---|---|
N (%) or Mean (s.d.) | N (%) or Mean (s.d.) | ||
Age | 39 (10.6) | 38 (10.6) | 0.33 |
Sex | 0.47 | ||
Male | 81(48%) | 282 (51%) | |
Female | 88 (52%) | 270(49%) | |
Ethnicity | 0.35 | ||
Hispanic/Latino | 22 (13%) | 88(16%) | |
Non-Hispanic/Non-Latino | 147 (87%) | 464 (84%) | |
Race | 0.12 | ||
White | 155 (92%) | 482 (87%) | |
Non-white | 14 (8%) | 70 (13%) | |
Education | 0.001 | ||
High School or less | 40 (24%) | 127 (23%) | |
Technical School | 38 (22%) | 124 (22%) | |
Associate/Bachelor Degree | 66 (39%) | 144 (26%) | |
Post-College Graduate Degree | 11 (7%) | 53 (10%) | |
Unknown/Missing | 14 (8%) | 104 (19%) | |
Relatedness to Recipient | 0.19 | ||
Biologically related | |||
Parent | 8 (5%) | 18 (3%) | |
Child | 48 (28%) | 189 (34%) | |
Sibling | 37 (22%) | 84 (15%) | |
Other biological | 16 (9%) | 51 (10%) | |
Not biologically related | |||
Spouse | 7 (4%) | 40 (7%) | |
Other nonbiological | 46 (28%) | 149 (28%) | |
Unrelated | 4 (2%) | 3 (1%) | |
Missing | 3 (2%) | 18 (3%) | |
Recipient Liver Disease | |||
ETOH | 7 (4%) | 35 (6%) | |
Not ETOH | 162 (96%) | 517 (94%) | 0.29 |
Donation Status | 0.03 | ||
Donated | 66 (39%) | 175 (32%) | |
Accepted, but did not donate*** | 8 (5%) | 60 (11%)** | |
Not Accepted to Donate | 95 (56%) | 316 (57%) | |
Reason for Non-Acceptance | 0.75 | ||
Medical Contraindications | 79 (83%) | 272 (86%) | |
Non-Medical Contraindications | 7 (7%) | 21 (7%) | |
Declined To Donate | 9 (9%) | 23 (7%) |
Of 169 donors who attempted the MacLiver, files for 93 could be recovered and scored.
Excluded one donor who had no accept or decline information.
Reasons for non-donation after acceptance related to recipient condition included: candidate condition worsened/removed from transplant consideration, candidate condition improved/removed from transplant consideration, or candidate received a DDLT.
Inter-rater reliability of MacLiver scoring
For a subset (n=31) of MacLiver recordings, in addition to scoring by the study neuropsychologist (JF), a trained research assistant provided a second independent rating to assess scoring reliability. Of the scorable items, 90% matched exactly and four items (1%) differed by two points (Table 2). Three of the four were for the same prospective LD, the first one co-rated. The differences were due to conflicting conventions on whether LD response material given later in the questioning could be credited to an earlier question. By consensus, subsequent scoring allowed all information to be credited to any question. For the subsequent analyses of co-rated participants, the average rater scores were used.
Table 2.
Audio only (n=8) |
Audio + Video (n=23) |
|||||||
---|---|---|---|---|---|---|---|---|
Domain | Exact match | 1 category different |
2 categories different |
Kappa | Exact match | 1 category different |
2 categories different |
Kappa |
Understanding | 76 (89%) | 8 (9%) | 1 (1%) | 0.80 | 226 (95%) | 13 (5%) | 0 | 0.89 |
Appreciation | 21 (91%) | 2 (9%) | 0 | 0.70 | 53 (83%) | 10 (16%) | 1 (1%) | 0.63 |
Reasoning | 14 (88%) | 2 (12%) | 0 | 0.76 | 32 (76%) | 9 (21%) | 1 (3%) | 0.54 |
Final choice | 15 (94%) | 1 (6%) | 0 | 0.64 | 39 (93%) | 2 (5%) | 1 (2%) | 0.70 |
All Domains | 126 (90%) | 13 (9%) | 1 (1%) | 0.79 | 350 (90%) | 34 (9%) | 3 (1%) | 0.80 |
There was no significant difference in the proportion of exact matches between Audio only and Audio+Video for any domain or overall.
When the inter-rater reliability was examined for the four domains, ratings for Appreciation and Reasoning appeared to have more discrepancies than for Understanding and Final Choice, which may indicate greater subjectivity in scoring those components. Differences in total score (maximum total score = 36) ranged from −3 to +2, and raters were not systematically different (paired t-test, df=30, p=0.20). The absence of video did not affect inter-rater reliability (Table 2), but the presence of video provided information about rare but important contextual influences on participants’ responses (e.g., one respondent holding an infant, and another being given answers by another person in the room).
Distribution of scores
Figure 1(a) shows boxplots of the score distributions for the four elements of competence (Understanding, Appreciation, Reasoning, and Final Choice), and Figure 1(b) shows the subscale scores for each area of Understanding, both for those scored with audio information only (A), and those with both audio and video information (AV). No significant differences between the A and AV groups were seen for any of the MacLiver scales (two-sample t-test, df=91: Understanding, p=0.52; Appreciation, p=0.82; Reasoning, p=0.09; Final Choice, p=0.49). Table 3 gives means and standard deviations for each domain (combining A and AV). The total score is not reported since it is not clinically interpretable; competence can be impaired by poor performance on any one domain even if intact across other domains (14).
Table 3.
Understanding (max=22) |
Appreciation (max=6) |
Reasoning (max=4) |
Final Choice (max=4) |
||
---|---|---|---|---|---|
Characteristic | Mean±SD | Mean±SD | Mean±SD | Mean±SD | |
Overall | 18.1±2.6 | 5.1±1.0 | 3.1±0.8 | 3.8±0.5 | |
Age | |||||
≤ 38 years | 17.9±2.8 | 4.9±1.0 | 3.1±0.7 | 3.9±0.5 | |
>38 years | 18.4±2.4 | 5.2±1.0 | 3.1±0.9 | 3.8±0.5 | |
Sex | |||||
Female | 18.1±2.6 | 5.0±1.0 | 3.2±0.7 | 3.9±0.5 | |
Male | 18.1±2.7 | 5.1±1.1 | 3.0±0.8 | 3.8±0.5 | |
Ethnicity | |||||
Hispanic | 17.5±3.1 | 5.0±1.1 | 3.2±0.8 | 3.8±0.7 | |
Non-Hispanic | 18.2±2.6 | 5.1±1.0 | 3.1±0.8 | 3.8±0.5 | |
Race | |||||
Non-White | 17.0±3.0 | 5.1±0.5 | 3.0±0.0 | 3.9±0.2 | |
White | 18.2±2.6 | 5.1±1.1 | 3.1±0.8 | 3.8±0.5 | |
Education† | |||||
> High school | 19.0±2.1* | 5.2±0.9 | 3.3±0.8* | 3.8±0.5 | |
≤ High school | 17.5±2.7 | 4.9±1.2 | 2.9±0.7 | 3.8±0.5 | |
Relatedness to Recipient† | |||||
Biological | 18.1±2.7 | 5.1±1.0 | 3.1±0.8 | 3.8±0.5 | |
Non-biological | 18.1±2.6 | 5.0±1.1 | 3.1±0.7 | 3.8±0.4 | |
Accepted for Donation | |||||
Accepted | 18.2±2.6 | 5.1±1.0 | 3.1±0.8 | 3.8±0.5 | |
Not Accepted | 18.0±2.7 | 5.0±1.1 | 3.2±0.8 | 3.9±0.4 | |
Donated status | |||||
Donated | 18.2±2.6 | 5.0±1.0 | 3.1±0.8 | 3.8±0.6 | |
Not donated | 18.1±2.6 | 5.1±1.0 | 3.1±0.8 | 3.9±0.4 | |
Cause of liver failure in intended recipient | |||||
Alcohol | 18.6±1.5 | 5.4±0.8 | 3.3±0.7 | 3.9±0.3 | |
Not alcohol | 18.1±2.7 | 5.0±1.0 | 3.1±0.8 | 3.8±0.5 |
SD = standard deviation
Education missing/unknown for n=17; Relatedness to recipient missing/unknown for n=20
Education effect for Understanding, p=0.006; Appreciation, p=0.1556; Reasoning, p=0.0241; Final Choice, p=0.8432
Of particular interest are those participants whose scores placed them in the lowest quartile on each of the competence-related abilities (i.e., below the box in Figure 1a). Although this study did not attempt to establish a quantitative cut-off for adequate performance of competence-related abilities, 18% to 20% of participants had scores one standard deviation or more below the mean on Understanding, Appreciation, or Reasoning. The participants falling into these categories did not differ from other participants on the basis of any demographic variable. There were perfect scores across all prospective LDs in expressing their understanding of the right to refuse further evaluation, and to do so without consequence. Near perfect ability to express a clear choice was also evident across the sample.
Association between MacLiver scores and demographics, relatedness, and donor disposition
Components of the MacLiver were assessed for differences among demographic subgroups (Table 3). No differences were seen by age, sex, ethnicity, race, relationship to the recipient, whether accepted for donation, or completed donation. In contrast, those with more education (Associate’s degree and higher versus technical degree and lower) had significantly higher MacLiver scores for both Understanding and Reasoning. Neither met the criterion for significance after Bonferroni adjustment, but it is unusual that both results were for the same variable.
Relation of MacLiver to local competence assessment
None of the prospective LDs evaluated by the MacLiver were subsequently deemed unable to provide informed consent to living donation by the local standard of psychiatric, psychological, and/or social worker assessments.
Impact of MacLiver on perceptions of donation
Both the MacLiver and 3-month post-donation survey were completed by 36 donors. These donors were as likely as donors who had not completed the MacLiver (n=87) to report that the information they had received was clear (94% vs. 95%), that they were well prepared for donation (82% vs. 83%), and that they had positive attitudes about living donation in retrospect (79% vs. 78%). However, the subset of donors completing the MacLiver was significantly less likely to report that the donation experience was ‘very’ or ‘pretty stressful’ (39% vs. 68%, p=0.006).
Discussion
The prospective enrollment of living liver donors in the A2ALL consortium provided an opportunity to develop and evaluate a standardized educational tool and quantitative assessment for competence-related abilities (MacLiver) in the setting of living liver donation. This was accomplished using a self-administered program designed for tablet computers, created specifically for the study. We aimed to develop a tool to augment center-specific donor evaluations by identifying areas of reduced donor comprehension and possible issues with donor competence to consent to liver donation.
The cohort of participants in the MacLiver process, though only 23% of the total prospective donor population, were similar to those who did not participate due to refusals and technical problems. There were no statistically or clinically meaningful differences in MacLiver performance based on donor demographics or disposition, beyond education (see below). Also, we found no MacLiver differences when comparing biological vs. non-biological potential donors, spouses vs. other categories, or alcohol as a cause of recipient liver failure vs. other categories.
We were pleased to find that all prospective donors could express their understanding that they had the right to refuse donation and further evaluation at any time, and do so without consequence. Nearly all could express a clear final choice about their decision. As expected, there was greater variability in Appreciation and Reasoning than in other domains, relative to the respective numbers of questions, which may be due to subjectivity in the scoring of these qualitative responses.
Education was associated with certain competence-related domains. Those with a higher level of education obtained higher MacLiver Understanding and Reasoning scores than those with less education, as has been observed with the MacCAT-CR in other settings (23). In addition to the impact of baseline education on scores, remedial education to enhance Understanding and Appreciation positively affected MacCAT-CR performance in depressed (24) and schizophrenic (25) participants assessed for competence to undergo treatment or consent to research.
Completing the MacLiver did not appear to affect prospective LDs’ satisfaction post-donation. Those who took the MacLiver did report less stress about the donation, but this could reflect either a causal effect or a selection of more resilient donors who consented to undergo the MacLiver. Whether personality traits differ between those willing to consent to an added research component and those who do not could be examined in a future study using a tool such as the NEO PI-3 (26). In general, however, it is not so surprising that the MacLiver, which was a small part of the entire donor evaluation process, had little lasting effect on donor preparedness or attitudes about donation.
The MacLiver provided insight into how prospective LDs with no prior education from the donor evaluation team demonstrate their competence-related abilities to understand, appreciate, reason, and express a clear choice in response to standardized preliminary education. It is premature to qualify these data as “normative,” but this sample was demographically consistent with the large range of prospective liver LDs seen in our multi-center retrospective experience and in other reports (13,14,16,17). Given that these abilities, as components of competence, are necessary for regulatory compliance, these data may offer useful guidance on improving the process of donor assessment.
Individual performances on the MacLiver revealed considerable variability. Although no individual scored more than 1 standard deviation below all domain means, several clear outliers appeared within specific domains. Such individuals may be a group whose performance warrants more in-depth evaluation; a tailored, individualized approach to education; or further assessment. The latter is currently under development (EJ Gordon, 1R03DK091786-01).
Among the MacLiver participants, we expected a low exclusion rate due to competence-related deficiencies because they were required to provide written informed consent before performing the MacLiver module. Across the nine participating transplant centers, the local standard of medical, psychosocial, and psychiatric evaluations yielded only two prospective LDs who were ruled out for “psychosocial contraindications.” These two scored near or above the sample mean on the MacLiver domains, illustrating that performance on competence-related measures is only one of several issues that may lead otherwise medically suitable participants to be declined as donors. Although the MacLiver provides useful clinical information, it does not replace clinical judgment. It does, however, reduce the potential for evaluator bias in determining donor eligibility, providing more rigorous protection to this donor population.
Our experience with the MacLiver can provide guidance for future implementations. Early administration of the MacLiver can yield a “needs assessment” of areas important to competence, which is consistent with the intent of the MacArthur Competence Assessment Tool for Clinical Research (15) and its use in other studies (16, 23, 24, 25). Use of the tablet to standardize the educational component at a prospective donor’s initial visit can be time-saving for center personnel and ensure that all prospective donors receive uniform instruction. Timely provision of MacLiver scores to center staff can highlight the need for additional education to aid the potential LD in decision-making. Retention of knowledge could be tested at a second visit to assess how well a prospective donor sustains competency over time. Increased educational consistency, protecting prospective LDs by identifying atypical performance, and timely assessment with minimal investment of center resources are the main strengths of this method.
A bitter lesson from our study was the importance of thoroughly testing computer technology before use in the clinic. Although we had reviewed and approved the MacLiver educational segments, which were well done and well received, we did not sufficiently test the data acquisition and upload features. Centers had a variety of technical issues, some of which were difficult to solve. Delays occurred due to communication lags between the data coordinating center, the clinical centers, and Clinaero. In spite of these problems, we would still recommend a video interface for the educational components, which was successful in our implementation. For the query components, the video recording of subjects’ answers, which require scoring by a psychologist, may not be feasible in terms of time or cost in a transplant clinic. One cost effective alternative would be a short answer or multiple choice test, preferably by computer so that scores could be immediately sent to relevant transplant staff for planning the next step of the donor evaluation process.
There are important limitations to the study. First, the MacCAT-CR format on which the MacLiver is based was developed for live interaction with an experienced interviewer, wherein participants have repeated opportunity to demonstrate the extent of their decisional abilities (27). Although probing an individual’s response could reveal either more or less comprehension, uncovering knowledge deficits and re-disclosing information are likely to result in higher scores via the “teach-back” method (28). With non-interactive computerized administration, this advantage was lost. Second, the technology used was not accessible to all patients due to a lack of familiarity with computers, limitations in communication ability, or language barriers (29). Third, the approach complicated the clinical flow. Study coordinators reported that the earlier arrival time required to take the MacLiver before clinical visits was a primary deterrent for the 77% who did not participate. Lastly, the technology had failures in recording and downloading responses and some users could not navigate the system effectively. These issues combined to create a substantial loss of potential participants for the MacLiver evaluation. Although we ascertained that the subset that attempted the MacLiver did not differ from the overall cohort on any measured dimension, the possibility of unmeasured differences cannot be excluded. In future implementations, computer literacy and language capacity could be accommodated, e.g., by provision of a brief computer-training program or providing translated versions for common non-English languages (30). An advantage of the MacLiver is that it provided a uniform instructional approach to potential donors at all nine A2ALL clinical centers. If updated to include current federally mandated, consensus driven information, it may be useful as a preliminary education tool that could be viewed at the start of an initial prospective LD clinic visit.
In conclusion, we have evaluated a novel approach for standardized education and assessment of competence in prospective liver donors. Potential donors who were judged competent by conventional local assessments generated a range of presumably acceptable MacLiver scores, but also included outliers who may need tailored evaluation and education. Despite methodological difficulties, this is an important first step in implementing standardized education and preparation for competence assessment among potential liver donors.
Supplementary Material
Acknowledgment
The authors acknowledge the contributions of the following study coordinators, coinvestigators, and administrative assistants at each of the participating institutions: Andrea Herman, R.N., Carlos Garcia, Michelle Jaramillo, and Rita Lerner at the University of Colorado Denver, Aurora, CO; Janet Mooney at the University of California, Los Angeles, CA; Dulce MacLeod, R.N., at the University of California, San Francisco, LA; Colleen Green and Royanne Dell, R.N., at the University of Virginia, Charlottesville, VA; Patrice Al-Saden at Northwestern University, Chicago, IL; Scott Heese at Columbia University, New York, NY; and Charlotte Hoffman at the Virginia Commonwealth University, Richmond, VA.
The patients participating in this trial were enrolled in the National Institutes of Health (NIH)-sponsored Adult-to-Adult Living Donor Liver Transplantation Cohort Study. This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) through cooperative agreements (NIDDK grant nos.: U01-DK62536, U01-DK62444, U01-DK62467, U01-DK62483, U01-DK62484, U01-DK62494, U01-DK62496, U01-DK62498, U01-DK62505, and U01-DK62531). The trial was also funded by research grants from Schering-Plough, through a cooperative research and development agreement with NIH-NIDDK, and through a clinical trial agreement between Ortho-Biotech and NIH-NIDDK. This study was supported by the NIDDKD through cooperative agreements (listed in parentheses). Additional support was provided by the Health Resources and Services Administration and the American Society of Transplant Surgeons.
Appendix A
The A2ALL Study Group includes Northwestern University, Chicago, IL; University of California – Los Angeles, CA; University of California – San Francisco, CA; University of Colorado Health Sciences Center, Denver, CO; University of North Carolina, Chapel Hill, NC; Epidemiology and Clinical Trials Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; University of Michigan, Ann Arbor, MI; Department of Surgery, Columbia Presbyterian Medical Center, New York, NY; University of Pennsylvania, Philadelphia, PA; Department of Internal Medicine, University of Virginia, Charlottesville, VA; and Virginia Commonwealth University, Richmond, VA. The following individuals were instrumental in the planning, conduct, and/or care of patients enrolled in this study at each of the participating institutions. Columbia University Health Sciences, New York, NY (DK62483): principal investigator, Jean C. Emond, M.D.; coprincipal investigator, Robert S. Brown, Jr.,M.D., M.P.H.; study coordinators, Scott Heese, B.A., and Taruna Chawla, M.D. Northwestern University, Chicago, IL (DK62467): principal investigator, Michael M.I. Abecassis, M.D., M.B.A.; coprincipal investigator, Laura M. Kulik, M.D.; study coordinator, Patrice Al-Saden, R.N., C.C.R.C. University of Pennsylvania Health System, Philadelphia, PA (DK62494): principal investigator, Abraham Shaked, M.D., Ph.D.; coprincipal investigator, Kim M. Olthoff, M.D.; study coordinators, Brian Conboy, P.A., M.B.A., and Mary Shaw, R.N., B.B.A. University of Colorado Health Sciences Center, Denver, CO (DK62536): principal investigator, Gregory T. Everson, M.D.; coprincipal investigator, Igal Kam, M.D.; study coordinator, Andrea Herman, R.N. University of California Los Angeles, Los Angeles, CA (DK62496): principal investigator, Johnny C. Hong, M.D.; coprincipal investigator, Ronald W. Busuttil, M.D., Ph.D.; study coordinator, Janet Mooney, R.N., B.S.N. The principal investigator for LADR was Sammy Saab, M.D. University of California San Francisco, San Francisco, CA (DK62444): principal investigator, Chris E. Freise, M.D., F.A.C.S.; coprincipal investigator, Norah A. Terrault, M.D.; study coordinator, Dulce MacLeod, R.N. University of Michigan Medical Center, Ann Arbor, MI (DK62498): principal investigator, Robert M. Merion, M.D.; data coordinating center staff, Anna S.F. Lok, M.D., Akinlolu O. Ojo, M.D., Ph.D., Brenda W. Gillespie, Ph.D., Margaret Hill-Callahan, B.S., L.S.W., Terese Howell, B.S., C.C.R.C., Lisa Holloway, B.S., C.C.R.C., Monique Lowe, M.S., Abby Smith, B.A., and Abby Brithinee, B.A. University of North Carolina, Chapel Hill, NC (DK62505): principal investigator, Paul H. Hayashi, M.D., M.P.H.; study coordinator, Tracy Russell, M.A. University of Virginia (DK62484): principal investigator, Carl L. Berg, M.D.; study coordinator, Jaye Davis, R.N., and Colleen Green, P.A. The principal investigator for LADR was Abdullah M.S. Al-Osaimi, M.D. Medical College of Virginia Hospitals, Virginia Commonwealth University, Richmond, VA (DK62531): principal investigator, Robert A. Fisher, M.D., F.A.C.S.; coprincipal investigator, R. Todd Stravitz, M.D.; study coordinators, April Ashworth, R.N., Andrea Lassiter, B.S., and Charlotte Hoffman, R.N. The principal investigator for LADR was Mitchell Shiffman, M.D. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD: James E. Everhart, M.D., M.P.H., Averell Sherker, M.D., and Jay H. Hoofnagle, M.D.
Footnotes
Author contributions:
Jason Freeman participated in conducting the research via hypothesis generation, data collection and analysis, and with the writing and editing of the paper.
Jean Emond participated in the research design, writing of the paper, and the data analysis.
Brenda W. Gillespie participated in research design, the writing of the paper, and in data analysis.
Paul S. Appelbaum participated in research design and in the writing of the paper.
Robert Weinrieb participated in the research design and in the writing of the paper.
Peg Hill-Callahan participated in the writing of the paper and in the performance of the research.
Elisa J. Gordon participated in the writing of the paper.
Norah Terrault participated in the research design, writing of the paper, and performance of the research.
James Trotter participated in the research design, performance of the research, and in the data analysis.
April Ashworthparticipated in the writing of the paper and performance of the research
Mary Amanda Dew participated in data analysis and in the writing of the paper.
Timothy Pruettparticipated in the research design, the writing of the paper, and the performance of the research.
References
- 1.Berg CL, Gillespie BW, Merion RM, Brown RS, Jr, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE A2ALL Study Group. Improvement in Survival Associated with Adult-to-Adult Living Donor Liver Transplantation. Gastroenterology. 2007;6(133):1806–1183. doi: 10.1053/j.gastro.2007.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303:959–966. doi: 10.1001/jama.2010.237. [DOI] [PubMed] [Google Scholar]
- 3.Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl. 2006;12:1485–1488. doi: 10.1002/lt.20875. [DOI] [PubMed] [Google Scholar]
- 4.Ratner LE, Sandoval PR. When Disaster Strikes: Death of a Living Organ Donor. Am J Transplant. 2010;10:2577–2581. doi: 10.1111/j.1600-6143.2010.03341.x. [DOI] [PubMed] [Google Scholar]
- 5.Appelbaum PS, Grisso T. MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) Sarasota, FL: Professional Resource Press; 2001. [Google Scholar]
- 6.Faden R, Beauchamp TL. A History and Theory of Informed Consent. Oxford Univ Press; 1986. [Google Scholar]
- 7.Delmonico FL. Vancouver forum on the live lung, liver, pancreas, and intestine donor. Transplantation. 2006;82:1245. doi: 10.1097/01.tp.0000241233.43707.25. [DOI] [PubMed] [Google Scholar]
- 8.Pruett TL, Tibell A, Alabdulkareem A, Bhandari M, Cronin DC, Dew MA, Dib-Kuri A, Gutmann T, Matas A, McMurdo L, Rahmel A, Rizvi SA, Wright L, Delmonico FL. The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation. 2006;81:1386–1387. doi: 10.1097/01.tp.0000214976.36526.e3. [DOI] [PubMed] [Google Scholar]
- 9.Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, Langnas AN, Delmonico FL. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006;81:1373–1385. doi: 10.1097/01.tp.0000216825.56841.cd. [DOI] [PubMed] [Google Scholar]
- 10.Rodrigue JR, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Mandelbrot DA. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at US transplant programs. Am J Transplant. 2007 Oct;7(10):2326–2332. doi: 10.1111/j.1600-6143.2007.01921.x. [DOI] [PubMed] [Google Scholar]
- 11.Parekh AM, Gordon EJ, Garg AX, Waterman AD, Kulkarni S, Parikh CR. Living kidney donor informed consent practices vary between US and non-US centers. Nephrol Dial Transplant. 2008 Oct;23(10):3316–3324. doi: 10.1093/ndt/gfn295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Housawi AA, Young A, Boudville N, Thiessen-Philbrook H, Muirhead N, Rehman F, Parikh CR, Al-Obaidli A, El-Triki A, Garg AX. Donor Nephrectomy Outcomes Research (DONOR) Network. Transplant professionals vary in the long-term medical risks they communicate to potential living kidney donors: an international survey. Nephrol Dial Transplant. 2007;22(10):3040–3045. doi: 10.1093/ndt/gfm305. [DOI] [PubMed] [Google Scholar]
- 13.Trotter JF, Wisniewski KA, Terrault NA, Everhart JE, Kinkhabwala M, Weinrieb RM, Fair JH, Fisher RA, Koffron AJ, Saab S, Merion RM A2ALL Study Group. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology. 2007;46:1476–1484. doi: 10.1002/hep.21845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Trotter JF, Gillespie BW, Terrault N, Abecassis MM, Merion RM, Brown RS, Jr, Olthoff KM, Hayashi PH, Berg CL, Fisher RA, Everhart JE Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Laboratory test results after living liver donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) Liver Transpl. 2011 Apr;17(4):409–417. doi: 10.1002/lt.22246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. Oxford University Press; 1998. [Google Scholar]
- 16.Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ. Competence of Depressed Patients for Consent to Research. Am J Psychiatry. 1999;156:1380–1384. doi: 10.1176/ajp.156.9.1380. [DOI] [PubMed] [Google Scholar]
- 17.Karlawish JHT, Casarett DJ, James BD. Alzheimer's Disease Patients' and Caregivers' Capacity, Competency, and Reasons to Enroll in an Early-Phase Alzheimer's Disease Clinical Trial. J Am Geriatr Soc. 2002;50(12):2019–2024. doi: 10.1046/j.1532-5415.2002.50615.x. [DOI] [PubMed] [Google Scholar]
- 18.Dunn L, Nowrangi MA, Palmer BW, Jeste DV, Saks ER. Assessing Decisional Capacity for Clinical Research or Treatment: A Review of Instruments. Am J Psychiatry. 2006;163:1323–1334. doi: 10.1176/ajp.2006.163.8.1323. [DOI] [PubMed] [Google Scholar]
- 19.Simmons R, Marine S, Simmons R Gift of Life. the effect of Organ Transplantation on the Individual, Family and Societal Dynamics. NJ: Transaction Publishers; 1987. [Google Scholar]
- 20.Padilla MA, Divers J, Vaughan LK, Allison DB, Tiwari HK. Multiple imputation to correct for measurement error in admixture estimates in genetic structured association testing. Hum Hered. 2009;68:65–72. doi: 10.1159/000210450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Little RJA, Rubin DB. Statistical Analysis with Missing Data. 2nd edition. Hoboken, NJ: John Wiley & Sons; 2002. [Google Scholar]
- 22.Little R, Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 1996;52:1324–1333. [PubMed] [Google Scholar]
- 23.Candilis PJ, Fletcher KE, Geppert CM, Lidz CW, Appelbaum PS. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically illnon-ill subjects. Schizophr Res. 2008;99:350–358. doi: 10.1016/j.schres.2007.11.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lapid MI, Rummans TA, Pankratz VS, Appelbaum PS. Decisional capacity of depressed elderly to consent to electroconvulsive therapy. J Geriatr Psychiatry Neurol. 2004;17:42–46. doi: 10.1177/0891988703261996. [DOI] [PubMed] [Google Scholar]
- 25.Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57:533–538. doi: 10.1001/archpsyc.57.6.533. [DOI] [PubMed] [Google Scholar]
- 26.McCrae RR, Costa PT, Martin TA. The NEO–PI–3: A more readable Revised NEO Personality Inventory. J Pers Assess. 2005;84(3):261–270. doi: 10.1207/s15327752jpa8403_05. [DOI] [PubMed] [Google Scholar]
- 27.Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163(1):83–90. doi: 10.1001/archinte.163.1.83. [DOI] [PubMed] [Google Scholar]
- 28.Institute of Medicine. Speaking of health. Assessing health communication strategies for diverse populations. Washington, DC: National Academy Press; 2002. [PubMed] [Google Scholar]
- 29.National Telecommunication and Information Administration. [Accessed December 2, 2010];A nation online: Entering the broadband age. 2004 http://www.ntia.doc.gov/reports/anol/index.html.
- 30.Lai AM, Kaufman DR, Starren J, Shea S. Evaluation of a remote training approach for teaching seniors to use a telehealth system. Int J Med Inform. 2009 Nov;78(11):732–44. doi: 10.1016/j.ijmedinf.2009.06.005. (Epub 2009 Jul 19). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.